Hydroxyurea does not appreciably reduce JAK2 V617F allele burden in patients with polycythemia vera or essential thrombocythemia

Lignende værker

• JAK2V617F allele burden and thrombosis: a direct comparison in essential thrombocythemia and polycythemia vera
  af: Carobbio, Alessandra, et al.
  Udgivet: (2009)
• An agenda for future research projects in polycythemia vera and essential thrombocythemia
  af: Barbui, Tiziano, et al.
  Udgivet: (2020)
• Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera
  af: Lussana, Federico, et al.
  Udgivet: (2017)
• Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?
  af: Barbui, Tiziano, et al.
  Udgivet: (2009)
• JAK2V617F mutational status and allele burden have little influence on clinical phenotype and prognosis in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis
  af: Guglielmelli, Paola, et al.
  Udgivet: (2009)